Oral contraceptive use and the risk of breast cancer

被引：34

作者：

Casey, Petra M. ^{[1
]}

Cerhan, James R. ^{[2
]}

Pruthi, Sandhya ^{[3
]}

机构：

[1] Mayo Clin, Dept Obstet & Gynecol, Rochester, MN 55905 USA

[2] Mayo Clin, Div Epidemiol, Rochester, MN 55905 USA

[3] Mayo Clin, Breast Diagnost Clin, Rochester, MN 55905 USA

来源：

MAYO CLINIC PROCEEDINGS | 2008年 / 83卷 / 01期

关键词：

D O I：

10.4065/83.1.86

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

The clinical impact of the association between oral contraceptive (OC) use and breast cancer risk is important given that OCs are the most commonly prescribed contraceptive agent and that more than a quarter of a million women are diagnosed as having breast cancer in the United States annually. Substantial changes to OC formulations have been made during the past decade, and this review focuses on recent OC trends and risks and benefits. We also have a better understanding of how estrogen affects breast carcinogenesis; research on this topic is ongoing and has the goal of decreasing breast cancer incidence and mortality.

引用

页码：86 / 91

页数：6

共 34 条

[1]

[Anonymous], IARC MON EV CARC RIS

[2]

Association of Reproductive Health Professionals, 2002, EXT REG OR CONTR

[3]

BENSYL DM, 2002, MMWR SURVEILL SUMM, V54, P1

[4]

Effect of screening and adjuvant therapy on mortality from breast cancer [J].

Berry, DA ;

Cronin, KA ;

Plevritis, SK ;

Fryback, DG ;

Clarke, L ;

Zelen, M ;

Mandelblatt, JS ;

Yakovlev, AY ;

Habbema, JDF ;

Feuer, EJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (17) :1784-1792

[5]

BREEN N, 2007, CANCER, P2405

[6]

Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study:: A report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group [J].

Brohet, Richard M. ;

Goldgar, David E. ;

Easton, Douglas F. ;

Antoniou, Antonis C. ;

Andrieu, Nadine ;

Chang-Claude, Jenny ;

Peock, Susan ;

Eeles, Rosalind A. ;

Cook, Margaret ;

Chu, Carol ;

Nogues, Catherine ;

Lasset, Christine ;

Berthet, Pascaline ;

Meijers-Heijboer, Hanne ;

Gerdes, Anne-Marie ;

Olsson, Hakan ;

Caldes, Trinidad ;

van Leeuwen, Flora E. ;

Rookus, Matti A. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (25) :3831-3836

[7]

BURKMAN R, 2002, CLINICIAN, V20, P3

[8]

Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5

[9]

CLARKE CA, 2006, J CLIN ONCOL, pE49

[10]

Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment [J].

Cogliano, V ;

Grosse, Y ;

Baan, R ;

Straif, K ;

Secretan, B ;

El Ghissassi, F .

LANCET ONCOLOGY, 2005, 6 (08) :552-553

← 1 2 3 4 →